Copyright
©The Author(s) 2024.
World J Cardiol. Nov 26, 2024; 16(11): 651-659
Published online Nov 26, 2024. doi: 10.4330/wjc.v16.i11.651
Published online Nov 26, 2024. doi: 10.4330/wjc.v16.i11.651
Name of disease | Typical features | Means of identification |
HCM | Asymmetric septal hypertrophy, often accompanied by left ventricular outflow tract obstruction | Genetic testing and cardiac MRI |
Hypertensive heart disease | Symmetrical myocardial hypertrophy, generally, ventricular wall thickness is ≤ 15 mm | History of hypertension for many years |
Fabry disease | Concentric hypertrophy | α-Galactosidase A activity assay, GLA gene test |
Myocardial amyloidosis | Symmetrical myocardial hypertrophy, characterized on electrocardiography by low voltage or normal voltage | Radionuclide imaging, cardiac biopsy line histology and amyloid staining |
Physiological hypertrophy | In athletes, the unique condition of mild, uniform left ventricular wall thickening may be accompanied by an increase in left ventricular cavity diameter | Cardiopulmonary exercise test |
- Citation: Ma BS, Zhai SH, Chen WW, Zhao QN. Cardiac hypertrophy in polycythemia vera: A case report and review of literature. World J Cardiol 2024; 16(11): 651-659
- URL: https://www.wjgnet.com/1949-8462/full/v16/i11/651.htm
- DOI: https://dx.doi.org/10.4330/wjc.v16.i11.651